Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during gram-negative pneumonia

Molecular Medicine

Volumn 18, Issue 7, 2012, Pages 1067-1075

  Hoogerwerf, Jacobien J ^a   van der Windt, Gerritje J W ^a   Blok, Dana C ^a   Hoogendijk, Arie J ^a   de Vos, Alex F ^a   van't Veer, Cornelis ^a   Florquin, Sandrine ^a   Kobayashi, Koichi S ^b   Flavell, Richard A ^c   van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH INHIBITION; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; KLEBSIELLA PNEUMONIAE INFECTION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL RATE; TISSUE INJURY; WILD TYPE;

ANIMALS; CELL MOVEMENT; CHEMOKINES; HOST-PATHOGEN INTERACTIONS; IMMUNITY; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-6; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; NEUTROPHILS; PHAGOCYTOSIS; PNEUMONIA; PNEUMONIA, BACTERIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866754801     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00450     Document Type: Article

References (42)

1. Beutler BA. (2009) TLRs and innate immunity. Blood. 113:1399-407.
2. van der Poll T, Opal SM. (2008) Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8:32-43.
3. Liew FY, Xu D, Brint EK, O'Neill LA. (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446-58.
4. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S (2008) Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe. 3:352-63.
5. Dinarello CA. (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-50.
6. Kobayashi K, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:191-202.
7. van't Veer C, et al. (2007) Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179:7110-20.
8. Wiersinga WJ, et al. (2009) Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit. Care Med. 37:569-76.
9. Deng JC, et al. (2006) Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 116:2532-42.
10. Annane D, Bellissant E, Cavaillon JM. (2005) Septic shock. Lancet 365:63-78.
11. Balaci L, et al. (2007) IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 80:1103-14.
12. Lagler H, et al. (2009) TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J. Immunol. 183:2027-36.
13. Rijneveld AW, et al. (2004) Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood. 103:1702-9.
14. Renckens R, et al. (2007) Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood. 109:1593-601.
15. Knapp S, et al. (2004) Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol. 172:3132-8.
16. Wiersinga WJ, et al. (2007) Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med. 4:e248.
17. Wiersinga WJ, Wieland CW, Roelofs JJ, van der Poll T. (2008) MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One. 3:e3494.
18. van der Windt GJ, van't Veer C, Florquin S, van der Poll T. (2010) CD44 deficiency is associated with enhanced Escherichia coli-induced proinflammatory cytokine and chemokine release by peritoneal macrophages. Infect. Immun. 78:115-24.
19. van der Windt GJ, et al. (2011) Osteopontin impairs host defense during pneumococcal pneumonia. J. Infect. Dis. 203:1850-8.
20. Strieter RM, Belperio JA, Keane MP. (2002) Cytokines in innate host defense in the lung. J. Clin. Invest. 109:699-705.
21. Mizgerd JP. (2008) Acute lower respiratory tract infection. N. Engl. J. Med. 358:716-27.
22. Tsai WC, et al. (1998) Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 161:2435-40.
23. Ye P, et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-27.
24. Kolls JK, McCray PB Jr, Chan YR. (2008) Cyto-kine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8:829-35.
25. Chan YR, et al. (2009) Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J. Immunol. 182:4947-56.
26. Jeyaseelan S, et al. (2005) Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am. J. Respir. Cell Mol. Biol. 32:531-9.
27. Cai S, Zemans RL, Young SK, Worthen GS, Jeyaseelan S. (2009) Myeloid differentiation protein-2-dependent and-independent neutrophil accumulation during Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol. 40:701-9.
28. Aujla SJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-81.
29. Armstrong GL, Conn LA, Pinner RW. (1999) Trends in infectious disease mortality in the United States during the 20th century. JAMA. 281:61-6.
30. Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S. (2009) Both TRIF-and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J. Immunol. 183:6629-38.
31. Volk HD, Reinke P, Docke WD. (2000) Clinical aspects: from systemic inflammation to 'immu-noparalysis'. Chem. Immunol. 74:162-77.
32. Hotchkiss RS, Karl IE. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-50.
33. Liu ZJ, et al. (2008) Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J. Surg. Res. 150:34-9.
34. Branger J, et al. (2004) Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect. Immun. 72:788-94.
35. Schurr JR, et al. (2005) Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect. Immun. 73:532-45.
36. Bhan U, et al. (2007) TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J. Immunol. 179:3937-46.
37. Tanabe M, et al. (2005) Compensatory response of IL-1 gene knockout mice after pulmonary infection with Klebsiella pneumoniae. J. Med. Microbiol. 54:7-13.
38. Seki M, et al. (2010) Critical role of IL-1 receptorassociated kinase-M in regulating chemokinedependent deleterious inflammation in murine influenza pneumonia. J. Immunol. 184:1410-8.
39. Le Goffic R, et al. (2006) Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virusinduced acute pneumonia. PLoS Pathog. 2:e53.
40. Si-Tahar M, Touqui L, Chignard M. (2009) Innate immunity and inflammation-two facets of the same anti-infectious reaction. Clin. Exp. Immunol. 156:194-8.
41. Wang S, et al. (2010) Influenza virus-cytokineprotease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J. Infect. Dis. 202:991-1001.
42. Teijaro JR, et al. (2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 146:980-91.